Literature DB >> 3174035

Vitrectomy and scleral buckling methods for proliferative vitreoretinopathy.

A M Hanneken1, R G Michels.   

Abstract

The authors operated on 95 eyes with retinal detachment (RD) complicated by proliferative vitreoretinopathy (PVR) using vitrectomy combined with scleral buckling. The retina was successfully reattached in 10 (91%) of 11 eyes with mild PVR (B, C1), 14 (93%) of 15 eyes with moderate PVR (C2-C3), and 52 (75%) of 69 eyes with severe PVR (D1-D3). Thirteen (88%) of 15 eyes in which silicone oil was injected were successfully reattached. Eighty-eight percent of the 76 successfully reattached cases had a postoperative visual acuity of 5/200 or better; the median postoperative visual acuity was 20/200. Severe PVR was the cause of failure in 17 (89%) of 19 eyes in which the retina was not reattached.

Entities:  

Mesh:

Year:  1988        PMID: 3174035     DOI: 10.1016/s0161-6420(88)33081-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  Design features and surgical use of a cannulated extrusion needle.

Authors:  H W Flynn; W G Lee; J M Parel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

Review 2.  Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.

Authors:  D G Charteris
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

3.  Non-buckled vitrectomy for retinal detachment with inferior breaks and proliferative vitreoretinophathy.

Authors:  Yan Sheng; Wen Sun; Bin Mo; Ya-Jie Yu; Yang-Shun Gu; Wu Liu
Journal:  Int J Ophthalmol       Date:  2012-10-18       Impact factor: 1.779

4.  Intraocular perfluorodecalin and silicone oil tamponade (double filling) in the management of complicated retinal detachment: functional and anatomical outcomes using small-gauge surgery.

Authors:  Emma Clara Zanzottera; Alessandro Marchese; Francesco Bandello; Michele Coppola
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-09-22       Impact factor: 3.535

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.